Timing of Complete Revascularization with Multivessel PCI for Myocardial Infarction.

Stähli BE, Varbella F, Linke A, Schwarz B, Felix SB, Seiffert M, Kesterke R, Nordbeck P, Witzenbichler B, Lang IM, Kessler M, Valina C, Dibra A, Rohla M, Moccetti M, Vercellino M, Gaede L, Bott-Flügel L, Jakob P, Stehli J, Candreva A, Templin C, Schindler M, Wischnewsky M, Zanda G, Quadri G, Mangner N, Toma A, Magnani G, Clemmensen P, Lüscher TF, Münzel T, Schulze PC, Laugwitz KL, Rottbauer W, Huber K, Neumann FJ, Schneider S, Weidinger F, Achenbach S, Richardt G, Kastrati A, Ford I, Maier W, Ruschitzka F (2023)

Publication Type: Journal article

Publication year: 2023

Journal

Book Volume: 389

Pages Range: 1368-1379

Journal Issue: 15

DOI: 10.1056/NEJMoa2307823

Abstract

Background In patients with ST-segment elevation myocardial infarction (STEMI) with multivessel coronary artery disease, the time at which complete revascularization of nonculprit lesions should be performed remains unknown. Methods We performed an international, open-label, randomized, noninferiority trial at 37 sites in Europe. Patients in a hemodynamically stable condition who had STEMI and multivessel coronary artery disease were randomly assigned to undergo immediate multivessel percutaneous coronary intervention (PCI; immediate group) or PCI of the culprit lesion followed by staged multivessel PCI of nonculprit lesions within 19 to 45 days after the index procedure (staged group). The primary end point was a composite of death from any cause, nonfatal myocardial infarction, stroke, unplanned ischemia-driven revascularization, or hospitalization for heart failure at 1 year after randomization. The percentages of patients with a primary or secondary end-point event are provided as Kaplan-Meier estimates at 6 months and at 1 year. Results We assigned 418 patients to undergo immediate multivessel PCI and 422 to undergo staged multivessel PCI. A primary end-point event occurred in 35 patients (8.5%) in the immediate group as compared with 68 patients (16.3%) in the staged group (risk ratio, 0.52; 95% confidence interval, 0.38 to 0.72; P<0.001 for noninferiority and P<0.001 for superiority). Nonfatal myocardial infarction and unplanned ischemia-driven revascularization occurred in 8 patients (2.0%) and 17 patients (4.1%), respectively, in the immediate group and in 22 patients (5.3%) and 39 patients (9.3%), respectively, in the staged group. The risk of death from any cause, the risk of stroke, and the risk of hospitalization for heart failure appeared to be similar in the two groups. A total of 104 patients in the immediate group and 145 patients in the staged group had a serious adverse event. Conclusions Among patients in hemodynamically stable condition with STEMI and multivessel coronary artery disease, immediate multivessel PCI was noninferior to staged multivessel PCI with respect to the risk of death from any cause, nonfatal myocardial infarction, stroke, unplanned ischemia-driven revascularization, or hospitalization for heart failure at 1 year. (Supported by Boston Scientific; MULTISTARS AMI ClinicalTrials.gov number, NCT03135275.)

Authors with CRIS profile

Involved external institutions

University of Medicine / Universiteti i Mjekësisë Albania (AL) Inselspital, Universitätsspital Bern Switzerland (CH) Cardiocentro Ticino Switzerland (CH) Azienda Ospedaliera Nazionale SS.Antonio e Biagio e C.Arrigo Italy (IT) Universitätsspital Zürich (USZ) Switzerland (CH) Ospedale di Rivoli Italy (IT) Universitätsklinikum Carl Gustav Carus Dresden Germany (DE) Universitätsklinikum Schleswig-Holstein (UKSH) Germany (DE) Universitätsmedizin Greifswald / Universitätsklinikum Greifswald Germany (DE) Universitätsklinikum Hamburg-Eppendorf (UKE) Germany (DE) Universitätsklinikum Würzburg Germany (DE) HELIOS Kliniken Germany (DE) Medizinische Universität Wien Austria (AT) Universität Ulm Germany (DE) Albert-Ludwigs-Universität Freiburg Germany (DE) Klinikum Landkreis Erding Germany (DE) Azienda Ospedaliero-Universitaria di Parma / Parma University Hospital Italy (IT) University of Zurich / Universität Zürich (UZH) Switzerland (CH) Universitätsmedizin der Johannes Gutenberg-Universität Mainz Germany (DE) University of Glasgow United Kingdom (GB) Universitätsklinikum Jena Germany (DE) Klinikum rechts der Isar Germany (DE) Sigmund-Freud-Privatuniversität Wien (SFU) / Sigmund Freud University Austria (AT) IHF GmbH Institut für Herzinfarktforschung Germany (DE) Wiener Gesundheitsverbund Kliniken Austria (AT) Technische Universität München (TUM) Germany (DE)

How to cite

APA:

Stähli, B.E., Varbella, F., Linke, A., Schwarz, B., Felix, S.B., Seiffert, M.,... Ruschitzka, F. (2023). Timing of Complete Revascularization with Multivessel PCI for Myocardial Infarction. New England Journal of Medicine, 389(15), 1368-1379. https://doi.org/10.1056/NEJMoa2307823

MLA:

Stähli, Barbara E., et al. "Timing of Complete Revascularization with Multivessel PCI for Myocardial Infarction." New England Journal of Medicine 389.15 (2023): 1368-1379.

BibTeX: Download